MichaelHTomassonMD
Hematology • Iowa City, IAHematologic Oncology, Myeloproliferative Disorder Hematology-Oncology
Associate Professor, Internal Medicine, Washington University School of Medicine
Dr. Tomasson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
200 Hawkins Dr
Dept Of Internal Medicine
Iowa City, IA 52242Phone+1 314-362-9350Fax+1 314-454-7551- Is this information wrong?
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1994 - 1997
Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1992 - 1994
Stanford University School of MedicineClass of 1992
Certifications & Licensure
CA State Medical License 1993 - Present
IA State Medical License 2016 - 2025
MO State Medical License 2000 - 2017
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2009
Clinical Trials
- Tandem Stem Cell Transplantation for Non-Hodgkin's Lymphoma Start of enrollment: 2009 May 05
- Carfilzomib, Pegylated Liposomal Doxorubicin Hydrochloride, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma Start of enrollment: 2012 May 14
- Azacitidine in Patients Undergoing Matched Unrelated Stem Cell Transplantation Start of enrollment: 2013 Apr 15
- Join now to see all
Publications & Presentations
PubMed
- 9 citationsElranatamab in relapsed or refractory multiple myeloma: the MagnetisMM-1 phase 1 trial.Nizar J Bahlis, Caitlin L Costello, Noopur S Raje, Moshe Y Levy, Bhagirathbhai Dholaria, Melhem Solh, Michael H Tomasson, Michael A Damore, Sibo Jiang, Cynthia Basu, A...> ;Nature Medicine. 2023 Oct 1
- 1 citationsSex differences in cardiovascular disease and dysregulation in Down syndrome.Melissa L Bates, Anastasiia Vasileva, Laura D M Flores, Yana Pryakhina, Michelle Buckman, Michael H Tomasson, Lara R DeRuisseau> ;American Journal of Physiology. Heart and Circulatory Physiology. 2023 Apr 1
- 2 citationsUtilizing digital pathology and immunohistochemistry of p53 as an adjunct to molecular testing in myeloid disorders.Kai J Rogers, Ibrahim M Abukhiran, Sergei Syrbu, Michael Tomasson, Melissa Bates, Prajwal Dhakal, Sharathkumar Bhagavathi> ;Academic Pathology. 2023 Feb 1
- Join now to see all
Lectures
- Early Intensive Therapy in Multiple Myeloma Using Tandem Transplantation with Novel Conditioning and Two Years Maintenance: A Single Institution Experience2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- A Single Autologous Stem Cell Transplant (ASCT) Followed By Two Years of Post-Transplant Therapy in Recently Diagnosed Elderly Multiple Myeloma (MM) Patients. Safety a...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
Nanotherapy Effective in Mice with Multiple MyelomaMay 21st, 2015
Grant Support
- Genomics Of AML: Contribution Of Cytokine Signaling Pathways To LeukemogenesisNational Cancer Institute2008–2012
- Environment &Genetics Of Monoclonal Gammopathy Of Uncertain Significance (MGUS)National Institute On Aging2011
- Exploration Of Neurobeachin (Nbea)'S Role In Multiple MyelomaNational Cancer Institute2009–2010
- Genetic Progression Factors In Multiple Myeloma And MGUSNational Cancer Institute2006
- Molecular Analysis Of Transformation In Tel/Pdgfr MiceNational Cancer Institute2000–2003
- Molecular Analysis Of Transformation In Tel/Pdgfr MiceNational Cancer Institute1999
Hospital Affiliations
University of Iowa Hospitals and ClinicsIowa City, Iowa
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
